Prostate Cancer Therapeutics Market, By Drug Type, By Distribution Channel, By Geography

Description

Prostate Cancer Therapeutics Market is estimated to be valued at USD 22.2 Bn in 2026 and is expected to reach USD 29.3 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.1% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 22.2 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	8.10%	2033 Value Projection:	USD 29.3 Bn

Prostate cancer is the most common cancer among the geriatric male population. It is a major health concern, especially in developed countries with a greater proportion of elderly men being affected by it. According to European Association of Urology, 2016, the incidence is highest in Northern and Western Europe (> 200 per 100,000 men with age group > 70 years of age), while rates in Eastern and Southern Europe have showed a continuous increase. Thus, the introduction of innovative drugs for patients with prostate cancer is required to meet the unmet needs with satisfactory results. Currently, metastatic castration-resistant prostate cancer (CRPC) is usually treated with chemotherapy (docetaxel, and cabazitaxel) or secondary hormonal therapeutic agents such as abiraterone or Triptorelin. Immunotherapy with Sipuleucel-T is prescribed in treating asymptomatic or minimally metastatic CRPC without visceral metastasis.

Market Dynamics

The market is gaining significant traction due to continuous investment by research organizations and universities for the development of therapeutic products for the treatment of such tumors. Novel therapies are expected to be predominately approved in castration-resistant patients, and to compete with better-established treatments, such as Zytiga, Xtandi and generic docetaxel, or to act as adjuvants to established therapies. For instance, there is a strong pipeline of products such as Metformin (Mansoura University), Avelumab (Duke University Medical Center), LY2452473 (Dana-Farber Cancer Institute), which are in their phase 2 studies and are projected to enter the market in the near future. However, high cost and side effects associated with drugs can restraint the market growth.

Key features of the study:

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global prostate cancer therapeutics market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
Key companies covered as a part of this study include Johnson & Johnson, Astella, Inc, Sanofi-Aventis, Bayer AG, AstraZeneca Plc, Pfizer Inc., Dendreon Corporation (Sanpower Group Co. Ltd.), Ipsen Group, Tolmar Inc, Endo Pharmaceuticals, AbbVie, Inc.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, distribution channel upgrades, market expansion and marketing tactics.
The global prostate cancer therapeutics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for prostate cancer therapeutics market, research and consulting firms, new entrants and financial analysts
Various strategy matrices used in analyzing the prostate cancer therapeutics market would provide stakeholders vital inputs to make strategic decisions accordingly

Market Segmentation

By Drug Type (Revenue, USD Bn, 2021-2033)
- Hormonal Therapy
- Anti-androgens
- Immunotherapy
- Targeted Therapy
- Chemotherapy
By Distribution Channel (Revenue, USD Bn, 2021-2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Key Players
- Johnson & Johnson
- Astella, Inc
- Sanofi-Aventis
- Bayer AG
- AstraZeneca Plc
- Pfizer Inc.
- Dendreon Corporation (Sanpower Group Co. Ltd.)
- Ipsen Group
- Tolmar Inc
- Endo Pharmaceuticals
- AbbVie, Inc.

Product Code: CMI1257

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Regulatory Scenario
Reimbursement Scenario
Pipeline Analysis
PEST Analysis
PORTER'S Five Forces

4. Global Prostate Cancer Therapeutics Market, By Drug Type, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Hormonal Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Anti-Androgens
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Targeted Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Chemotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Prostate Cancer Therapeutics Market, By Distribution Channel, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Prostate Cancer Therapeutics Market, By Region, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, By Region, 2022-2033
North America
- Market Size and Forecast, By Drug Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
  - U.S.
  - Canada
Europe
- Market Size and Forecast, By Drug Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Drug Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
  - China
  - Japan
  - India
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Market Size and Forecast, By Drug Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
  - Brazil
  - Mexico
  - Rest of Latin America
Africa
- Market Size and Forecast, By Drug Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
  - Northern Africa
  - Central Africa
  - South Africa
Middle East
- Market Size and Forecast, By Drug Type, 2021-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, By Country, 2021-2033, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East

7. Competitive Landscape

Heat Map Analysis
Company Profiles
- Johnson & Johnson
  - Company Overview
  - Technology Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Astellas Pharma, Inc
  - Company Overview
  - Technology Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Sanofi
  - Company Overview
  - Technology Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Bayer AG
  - Company Overview
  - Technology Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- AstraZeneca Plc
  - Company Overview
  - Technology Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Pfizer, Inc.
  - Company Overview
  - Technology Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Dendreon Corporation (Sanpower Group Co. Ltd.)
  - Company Overview
  - Technology Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Ipsen Group
  - Company Overview
  - Technology Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Tolmar Inc
  - Company Overview
  - Technology Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Endo International plc
  - Company Overview
  - Technology Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- AbbVie, Inc.
  - Company Overview
  - Technology Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies

8. Section

Analyst Views
Research Methodology
About Us and Sales Contact